Advanced search
Publication Cover
International Journal of Cardiovascular Interventions Volume 3, 2000 - Issue 1
Journal homepage
9
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Basic principles of angiogenesis for the interventional cardiologist

Andrew Levy Rapapport Faculty of Medicine Technion-Israel Institute of Technology Haifa, Israel
&
Ariel Roguin Rapapport Faculty of Medicine Technion-Israel Institute of Technology Haifa, Israel
Pages 13-19 | Published online: 10 Jul 2009

  • Heniy TD. Therapeutic angiogenesis. BMJ 1999; 318: 1536-1539.
  • Chesboro JH, Knatterund G, Roberts et al. Thrombolysis in myocardial infarction (TIMI) phase 1; a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Circulation 1987; 76: 142-154.
  • Schaper W. Collateral circulation, I: collaterals in chronic coronary occlusion. In: Schaper W, ed. The Pathophysiology of Myocardial Perfusion. Amsterdam: Elsevier/NorthHolland Biomedical Press, 1979: 415-436.
  • Schaper W, DeBrabander M, Lewi P. DNA-synthesis and mitoses in coronary collateral vessels of the dog. Circ Res 1971; 28: 671-679.
  • Schaper W, Ito WD. Molecular mechanisms of coronary collateral vessel growth. Circ Res 1996; 79: 911-919.
  • Ware JA, Simons M. Angiogenesis is ischemic heart disease. Nat Med 1997; 3: 158-164.
  • Folkman J. Clinical applications of research on angiogenesis. N Engl J Med 1995; 333: 1757-1763.
  • Schultz A, Lavie L, Hochberg I et al. Interindividual heterogeneity in the hypoxic regulation of VEGF: significance for the development of the coronary artery collateral circulation. Circulation 1999; 100: 547-552.
  • Rivard A, Fabre JE, Silver M et al. Age-dependent impairment of angiogenesis. Circulation 1999; 99: 111-120.
  • Folkman J. Tumor angiogenesis. Adv Cancer Res 1985; 43:175-203.
  • lsner JM, Asahara T. Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. J Clin Invest 1999; 103: 1231-1236.
  • Benjamin LE, Golijanin D, Itin A, Pode D, Keshet E. Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. J Clin Invest 1999; 103: 159-165.
  • Beck E, D'Amore PA. Vascular development: cellular and molecular regulation. FASEB J 1997; 11: 365-373.
  • Sato T, Tozawa Y, Deutsch U et al. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 1995; 376: 70-74.
  • Asahara T, Chen D, Takahashi T et al. Tie-2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization. Circ Res 1998; 83: 233-240.
  • Shyu KG, Manor O, Magner M, Yancopoulos GD, Isner JM. Direct intramuscular injection of plasmid DNA encoding angiopoietin-1 but not angiopoietin-2 augments revascularization in the rabbit ischemic hindlimb. Circulation 1998: 98; 2081-2087.
  • Shing Y, Folkman J, Sullivan R, Butterfield C, Murray J, Klagsbrun M. Heparin affinity: purification of a tumorderived capillary endothelial cell growth factor. Science 1984; 223: 1296-1298.
  • Maciag T, Mehlman T, Friesel R, Schrieber A. Heparin binds endothelial cell growth factor, the principal mitogen in the bovine brain. Science 1984; 225: 932-935.
  • Baird A, Bohlen P, Esch F, Baird A, Gospodarowicz D. Acidic fibroblast growth factor (FGF) from bovine brain: amino-terminal sequence and comparison with basic FGF. EMBO J 1985; 4: 1951-1956.
  • Fett JW, Strydom DJ, Lobb RF et al. Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells. Biochemistiy 1985; 24: 5480-5486.
  • Taylor S, Folkman J. Protamine is an inhibitor of angiogenesis. Nature 1982; 297: 307-312.
  • Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 1997; 18: 1-22.
  • Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989; 246: 1306-1309.
  • Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxiainitiated angiogenesis. Nature 1992; 359: 843-845.
  • Levy AP, Levy NS, Wegner S, Goldberg MA. Transcriptional regulation of vascular endothelial growth factor by hypoxia. J Biol Chem 1995; 270:13333-13340.
  • Levy AP, Levy NS, Goldberg MA. Post-transcriptional regulation of vascular endothelial growth factor by hypoxia. J Biol Chem 1996; 271: 2746-2753.
  • Levy A, Levy NS, Loscalzo J et al. Regulation of vascular endothelial growth factor in cardiac myocytes. Circ Res 1995; 76: 758-766.
  • Levy NS, Chang S, Fumeaux HM, Levy AP. Hypoxie stabilization of VEGF mRNA by the RNA binding protein HuR. J Biol Chem 1998; 273: 6417-6423.
  • Fischer S, Sharma HS, Karliczek GF, Schaper W. Expression of vascular permeability factor/vascular endothelial growth factor in pig cerebral microvascular endothelial cells and its upregulation by adenosine. Mol Brain Res 1995; 28: 141-148.
  • Ferrara N. Role of vascular endothelial growth factor in the regulation of angiogenesis. Kidney Intern 1999; 56: 794-814.
  • Losordo DW, Vale PR, Isner JM. Gene therapy for myocardial angiogenesis. Am Heart J 1999; 138: S132-S141.
  • Isner JM, Pieczek A, Schainfeld R et al. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb. Lancet 1996; 348: 370-374.
  • Baumgartner I, Pieczek A, Manor O et al. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation 1998; 97: 1114-1123.
  • Lazarous DF, Unger EF, Epstein SE, Stine A, Arevalo JE, Quyyumi AA. Effect of basic fibroblast growth factor on lower extremity blood flow in patients with intermittent claudication: preliminary results. Circulation 1998; 98: 1456.
  • Schumacher MD, Pecher MD, von Sprecht BU, Stegmann T. Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease. Circulation 1998; 97: 645-650.
  • Sellke FW, Laham RJ, Edelman ER, Pearlman JD, Simons M. Therapeutic angiogenesis with basic fibroblast growth factor: technique and early results. Ann Thorac Surg 1998; 65: 1540-1544.
  • Henry TD, Rocha-Singh K, Isner JM et al. Results of intracoronary recombinant human vascular endothelial growth factor (rhVEFG) administration trial. J Am Coll Cardiol 1998; 31: 65A.
  • Losordo DW, Vale PR, Symes JF, et al. Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation 1998; 98: 2800-2804.
  • Henry TD, Annex BH, Azrin BA et al. Final results of the VIVA trial of rhVEGF for human therapeutic angiogenesis. Circulation 1999; 100: 1-477.
  • Symes JF, Losordo DW, Vale PR et al. Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease. Ann Thorac Surg 1999; 68: 830-836.
  • Ashara T, Banters C, Pastore CJ et al. Local delivery of vascular endothelial growth factor accelerates reendothelization and attenuates intimal hyperplasia in balloon injured rat carotid artery. Circulation 1995; 91: 2793-2801.
  • Nabel EG, Yang ZY, Plautz G et al. Recombinant growth factor -- 1 promotes intimai hyperplasia and angiogenesis in arteries in vivo. Nature 1993; 362: 844-846.
  • Inoue M, Itoh H, Ueda M et al. Vascular endothelial growth factor expression in human coronary atherosclerotic lesions; possible pathophysiological significance of VEGF in progression of atherosclerosis. Circulation 1998; 98: 2108-2116.
  • Hong MK, Kent KM, Mehran R et al. Continuous subcutaneous angiopeptin treatment significantly reduced neointimal hyperplasia in a porcine coronary in-stent restenosis model. Circulation 1997; 95: 449-454.
  • Laham RJ, Selke FW, Edelman ER et al. Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery. Circulation 1999; 100: 1865-1871.
  • Kornowski R, Fuchs S, Leon MB, Epstein SE. Delivery strategies to achieve therapeutic myocardial angiogenesis. Circulation 2000; 101: 454-459.
  • Yamamoto N, Kohmoto T, Gu A et al. Angiogenesis is enhanced in ischemic canine myocardium by transmyocardial laser revascularization. J Am Coll Cardiol 1998; 31: 1426-1433.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.